October 04, 2019
Pfizer Inc. is recalling 7824 bottles of ethosuximide capsules, 250 mg (NDC 59762-2250-2), that were distributed throughout the United States by Greenstone LLC. According to the October 2, 2019, US Food and Drug Administration (FDA) Enforcement Report, the product label includes an incorrect expiration date.
The recall affects 100-count bottles of ethosuximide capsules, 250 mg, from lot 3267079A. The expiration date listed on product label is September 2021, but it should be September 2020.
Pfizer initiated the voluntary recall September 12, 2019. The FDA designated the recall Class III on October 1, 2019. The classification suggests use of the recalled product is not likely to cause harm.
Ethosuximide is a prescription anticonvulsant used to treat people with epilepsy.